Loading compare…
6 funds hold both · as on May 2026
Comparing mutual fund co-ownership helps identify hidden asset concentration. Our reverse lookup database shows that 6 mutual funds hold active equity positions in both Metropolis Healthcare and Indoco Remedies. The scheme with the highest combined exposure is Tata India Innovation Fund (Tata MF), which holds a 2.34% stake in Metropolis Healthcare and a 0.46% stake in Indoco Remedies, amounting to a combined conviction weight of 2.80%.
When multiple mutual funds in your portfolio double-up on the same stock pairs, it limits your diversification benefits. If you also hold either of these companies directly in your demat account, your aggregate exposure is amplified. This co-ownership pattern is standard among index-tracking products but represents active, concentrated strategies in equity schemes.
| Fund | Metropolis wt. | Indoco wt. | Combined |
|---|---|---|---|
| Tata India Innovation FundTata MF · Sectoral / Thematic | 2.34% | 0.46% | |
| ICICI Prudential Pharma Healthcare and Diagnostics FundICICI Pru MF · Sectoral / Thematic | 1.54% | 0.47% | |
| Franklin India Small Cap Fund ^Franklin Templeton MF · Small Cap | 1.75% | 0.08% | |
| Nippon India Pharma FundNippon India MF · Sectoral / Thematic | 0.53% | 0.84% | |
| Nippon India Small Cap FundNippon India MF · Small Cap | 0.39% | 0.18% | |
| Back to IndexMotilal Oswal MF · Index Fund | 0.36% | 0.06% |
These funds hold both stocks — see how much their entire portfolios overlap.
Check overlap of top funds →“Holds both” = the fund discloses an equity position in each stock in its latest public monthly portfolio (as on May 2026). Weight = the position as a % of that fund's portfolio. ISIN-verified from AMC disclosures. Not investment advice.